244 related articles for article (PubMed ID: 8137886)
1. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
[TBL] [Abstract][Full Text] [Related]
2. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
[TBL] [Abstract][Full Text] [Related]
3. Complex ionic control of [3H]GBR 12783 binding to the dopamine neuronal carrier.
Héron C; Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1996 Apr; 301(1-3):195-202. PubMed ID: 8773464
[TBL] [Abstract][Full Text] [Related]
4. Cocaine and GBR 12783 recognize nonidentical, overlapping binding domains on the dopamine neuronal carrier.
Saadouni S; Refahi-Lyamani F; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Jul; 268(2):187-97. PubMed ID: 7957640
[TBL] [Abstract][Full Text] [Related]
5. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
Héron C; Costentin J; Bonnet JJ
Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
[TBL] [Abstract][Full Text] [Related]
6. Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: attempts to characterize the Na+ dependence of the neuronal transport of dopamine.
Amejdki-Chab N; Benmansour S; Costentin J; Bonnet JJ
J Neurochem; 1992 Nov; 59(5):1795-804. PubMed ID: 1402923
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes.
Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1993 Nov; 247(3):333-40. PubMed ID: 8307105
[TBL] [Abstract][Full Text] [Related]
8. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex.
Richfield EK
Mol Pharmacol; 1993 Jan; 43(1):100-8. PubMed ID: 8423763
[TBL] [Abstract][Full Text] [Related]
9. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
[TBL] [Abstract][Full Text] [Related]
10. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers.
Xu C; Coffey LL; Reith ME
Biochem Pharmacol; 1995 Jan; 49(3):339-50. PubMed ID: 7857321
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine.
Do-Régo JC; Hue H; Costentin J; Bonnet JJ
J Neurochem; 1999 Jan; 72(1):396-404. PubMed ID: 9886093
[TBL] [Abstract][Full Text] [Related]
12. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
[TBL] [Abstract][Full Text] [Related]
13. Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion.
Wu Q; Coffey LL; Reith ME
J Neurochem; 1997 Sep; 69(3):1106-18. PubMed ID: 9282933
[TBL] [Abstract][Full Text] [Related]
14. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
Vaugeois JM; Bonnet JJ; Costentin J
Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
[TBL] [Abstract][Full Text] [Related]
15. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats.
Valchar M; Hanbauer I
J Neurochem; 1993 Feb; 60(2):469-76. PubMed ID: 8419533
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a recombinant human dopamine transporter in multiple cell lines.
Eshleman AJ; Neve RL; Janowsky A; Neve KA
J Pharmacol Exp Ther; 1995 Jul; 274(1):276-83. PubMed ID: 7616409
[TBL] [Abstract][Full Text] [Related]
17. Prenatal cocaine alters dopamine transporter binding in postnatal day 10 rat striatum.
Collins LM; Meyer JS
Synapse; 1996 Aug; 23(4):335-43. PubMed ID: 8855519
[TBL] [Abstract][Full Text] [Related]
18. Effects of heavy metal cations and other sulfhydryl reagents on brain dopamine D1 receptors: evidence for involvement of a thiol group in the conformation of the active site.
Braestrup C; Andersen PH
J Neurochem; 1987 Jun; 48(6):1667-72. PubMed ID: 2952762
[TBL] [Abstract][Full Text] [Related]
19. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
Richfield EK
Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]